Last edition
News about "Emcure Pharmaceuticals "
Emcure Launches Poviztra to Broaden Access to Weight Management Therapy
Emcure has launched Poviztra, a once-weekly weight management therapy available in a pen device across five dosage strengths, with prices starting at INR 8,790 per month, aimed at improving access through convenient and precise dosing.
Emcure Pharmaceuticals | 22/12/2025 | By News Bureau
Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra in India
Under this agreement, Emcure becomes the first Indian company to hold exclusive rights for the distribution and commercialisation of the drug, expanding access to Novo Nordisk’s innovative semaglutide therapy for people living with overweight and obesity in the country.
Emcure Pharmaceuticals | 10/11/2025 | By Dineshwori | 274
Emcure Pharma Delivers Robust Performance Across All Businesses in Q1FY26: Satish Mehta
Emcure Pharmaceuticals reported strong financial results for the first quarter of FY26, demonstrating impressive growth in both domestic and international businesses.
Emcure Pharmaceuticals | 07/08/2025 | By Dineshwori | 355
Sanofi India, Emcure Sign Exclusive Distribution Partnership for Anti-Diabetic Drugs
Sanofi India Ltd. has entered into an exclusive distribution and promotion agreement with Emcure Pharmaceuticals for its oral anti-diabetic brands, including Amaryl and Cetapin, aiming to expand patient access and strengthen diabetes care across India.
Emcure Pharmaceuticals | 17/07/2025 | By Mrinmoy Dey | 237
Emcure Pharma Taps Industry Veteran R.S. Vasan to Lead India Business
Emcure Pharmaceuticals Ltd. has appointed R.S. Vasan as President – India Business and Senior Management Personnel (SMP).
Emcure Pharmaceuticals | 16/07/2025 | By Dineshwori | 298
Emcure Pharmaceuticals Launches its R&D Centre in Ahmedabad
The Emcure Research Centre (ERC) is strategically designed to enable breakthroughs in complex drug delivery systems, such as sustained-release formulations, liposomal injections and advanced dermal therapies.
Emcure Pharmaceuticals | 23/01/2025 | By Aishwarya | 676
Emcure Launches New Entity Emcutix Biopharmaceuticals for Dermatology Sector
As a part of this strategic initiative, Emcure's existing dermatology business will also operate under Emcutix.
Emcure Pharmaceuticals | 29/10/2024 | By Aishwarya | 827
Emcure Plans for Expansion and New Acquisitions with Upcoming IPO
Emcure Pharmaceuticals has been planning to expand its business as the upcoming initial public offering (IPO) will give the company access to new growth capital which it will use to fund inorganic growth and explore acquisitions.
Emcure Pharmaceuticals | 29/06/2024 | By Aishwarya | 1372
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy